1,019 filings
Page 14 of 51
8-K
vbvqxiey qhn814i
17 Apr 20
Entry into a Material Definitive Agreement
4:01pm
8-K
o4s3va 5iz
17 Apr 20
Submission of Matters to a Vote of Security Holders
12:00am
D
guqacxomy61quv
14 Apr 20
$2.08M in equity / options / securities to be acquired, sold $2.08M, 1 investor
12:00am
424B5
tfb xalsae
10 Apr 20
Prospectus supplement for primary offering
5:04pm
8-K
k5df3y45
10 Apr 20
Entry into a Material Definitive Agreement
4:08pm
8-K
0virk fskawj0mb
8 Apr 20
Trovagene to Present at the 19th Annual Needham Healthcare Conference
11:17am
8-K
52vz jwg0efvieq83
1 Apr 20
Other Events
1:54pm
424B5
0gax0
31 Mar 20
Prospectus supplement for primary offering
5:17pm
8-K
i2s5ch8 xjq1ttec
31 Mar 20
Entry into a Material Definitive Agreement
4:05pm
8-K
ibrh3fuybz rbwhs
5 Mar 20
Trovagene Announces Three New Nominees for Election to Board of Directors
10:38am
8-K
c5nik 5ag93qhcu
27 Feb 20
Trovagene Announces Fourth Quarter and Full-Year 2019 Results
4:15pm
SC 13G/A
majr9xswv
14 Feb 20
Beneficial ownership report (amended)
2:48pm
8-K
v4m7wdwn40
13 Feb 20
Other Events
10:00am
SC 13G/A
vc94sc5hsw2rs4jnj
6 Feb 20
Trovagene, Inc.
4:33pm
8-K
ebozlv1x
5 Feb 20
Trovagene to Present New Clinical Data for Onvansertib in Metastatic Castration-Resistant Prostate Cancer at ASCO Genitourinary Cancers Symposium
10:24am
8-K
pqotrlfecz0
30 Jan 20
Departure of Directors or Certain Officers
4:32pm
8-K
lp24s6pedrkqeoy
29 Jan 20
Trovagene Receives Approximately $1.45 Million From Exercise of Warrants
10:51am
8-K
mmkmxv
27 Jan 20
Other Events
10:59am